Jennifer Doudna’s $1 Billion Plan To Bring Gene Editing To The Masses - Forbes
Jennifer Doudna’s $1 Billion Plan To Bring Gene Editing To The Masses Forbes
Jennifer Doudna’s $1 Billion Plan To Bring Gene Editing To The Masses Forbes
Computation and deep-learning-driven advances in CRISPR genome editing Nature
Gene editing that spreads within the body could cure more diseases New Scientist
Successful World First: Baby Treated with Personalized CRISPR Gene Therapy for Rare Disease is Now ‘Thriving’ Good News Network
This CRISPR breakthrough turns genes on without cutting DNA ScienceDaily
Crispr Pioneer Launches Startup to Make Tailored Gene-Editing Treatments WIRED
A new CRISPR startup is betting regulators will ease up on gene-editing MIT Technology Review
Gene-edited babies are the future – but these CRISPR start-ups aren’t New Scientist
We can rewrite our genetic code: Best ideas of the century New Scientist
Souped-Up CRISPR Gene Editor Replicates and Spreads Like a Virus SingularityHub
Nanoparticle-based gene editing could expand treatment options for cystic fibrosis UCLA Health
Press Release Service: Watchmaker Genomics Licenses CRISPR-Cas9 Intellectual Property from Caribou Biosciences to Increase Throughput and Reduce Sequencing Cost per Sample CRISPR Medicine News
New gene-editing method could advance regenerative medicine UIC today
AI-powered CRISPR could lead to faster gene therapies, Stanford Medicine study finds Stanford Medicine
Democratizing CRISPR? Legal complexity, access and the right to science Nature
Clinical Hold Lifted On MAGNITUDE-2 Reshapes Intellia Gene Editing Risk Profile Yahoo Finance Singapore
Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3 The New England Journal of Medicine
First-in-human trial of CRISPR gene-editing therapy safely lowered cholesterol, triglycerides www.heart.org
Vertex’s CRISPR therapy rebounds in latest earnings BioPharma Dive
Press Release Service: Scribe Therapeutics Achieves Second Success Milestone for In Vivo Program in Collaboration with Eli Lilly and Company CRISPR Medicine News
CRISPR–Cas-inspired activator rescues Dravet syndrome mice CRISPR Medicine News
CRISPR vs cholesterol: can gene editing prevent heart disease? Nature
Harnessing artificial intelligence to advance CRISPR-based genome editing technologies Nature
Highlight: CRISPR Gene Editing Exposes Hidden Switch in Inflammatory Receptor CRISPR Medicine News
The hidden risks of CRISPR/Cas: structural variations and genome integrity Nature
Studies test whether gene-editing can fix high cholesterol. For now, take your medicine AP News
CRISPR: A Biotech Breakthrough National Science Foundation (.gov)
First CRISPR horses spark controversy: what’s next for gene-edited animals? Nature
CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia TCTMD.com
A boost for the precision of genome editing MIT News
Could CRISPR really cure these diseases? Labiotech.eu
Cleveland Clinic First-In-Human Trial of CRISPR Gene-Editing Therapy Shown to Safely Lower Cholesterol and Triglycerides Cleveland Clinic Newsroom
Could Crispr cure HIV? Chemistry World
CRISPR gene-editing works to reduce high cholesterol in a new study NPR
Therapeutic applications of CRISPR-Cas9 gene editing Frontiers
CRISPR-GPT for agentic automation of gene-editing experiments Nature
Scientists from China use CRISPR to remove HIV DNA from human cells CNBC TV18
Berkeley Talks: Nobel laureate Jennifer Doudna on CRISPR and the future of gene editing University of California, Berkeley
Why Is CRISPR Therapeutics Stock Surging Friday? - CRISPR Therapeutics (NASDAQ:CRSP) Benzinga
How CRISPR Gene Editing Saved Baby KJ National Press Foundation